Gilead Sciences (GILD) Misses Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $151.19 +1.06%
EPS Growth %: -13.8%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
VIVO, PMCB, PLCE, More
EPS Growth %: -13.8%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $3.03, $0.10 worse than the analyst estimate of $3.13. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $8.08 billion. Gilead Sciences reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
